PREVENTION OF CHOLELITHIASIS
- 作者: Tonkikh Y.1, Chukanov V.1, Vasyutin A.1, Bronnikov E.1
-
隶属关系:
- Research Institute of Medical Problems of the North
- 期: 卷 27, 编号 10 (2016)
- 页面: 41-43
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116656
- ID: 116656
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The paper gives evidence for the expediency and efficiency of preventing cholelithiasis, the important methods of which are to increase physical activity, to lose weight, and to modify a diet. It provides a rationale for using ursodeoxycholic acid in the risk group to prevent cholelithiasis.
全文:
作者简介
Yu. Tonkikh
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Candidate of Medical Sciences
V. Chukanov
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Professor
A. Vasyutin
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Candidate of Medical Sciences
E. Bronnikov
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Candidate of Biological Sciences
参考
- European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones // J. Hepatol. - 2016; 65 (1): 146-81.
- Тонких Ю.Л., Бронникова Е.П., Цуканов В.В. Распространенность и факторы риска заболеваний желчевыводящих путей у коренных жителей Тывы // Здравоохранение Российской Федерации. - 2014; 58 (5): 42-5.
- Агеева Е.С., Штыгашева О.В., Цуканов В.В. и др. Иммунологические особенности течения гастродуоденальной патологии у жителей Хакасии // Иммунология. - 2009; 30 (3): 162-4.
- Цуканов В.В., Куперштейн Е.Ю., Тонких Ю.Л. и др. Ассоциация жирнокислотного состава сыворотки крови с липидным составом желчи у больных холелитиазом // Тер. арх. - 2008; 80 (2): 71-5.
- Цуканов В.В., Куперштейн Е.Ю., Тонких Ю.Л. и др. Спектр жирных кислот и липидов сыворотки крови у больных холелитиазом // Клин. медицина. - 2009; 87 (2): 42-4.
- Chen L., Qiao Q., Zhang S. et al. Metabolicsyndrome and gallstone disease // World J.Gastroenterol. - 2012; 18: 4215-20.
- Stender S., Nordestgaard B., Tybjaerg-Hansen A. Elevated body mass indexas a causal risk factor for symptomatic gallstone disease: a mendelianrandomization study // Hepatology. - 2013; 58: 2133-41.
- Kriska A., Brach J., Jarvis B. et al. Physical activity and gallbladder disease determined by ultrasonography // Med. Sci. Sports Exerc. - 2007; 39: 1927-32.
- Banim P., Luben R., Wareham N. et al. Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study // Eur. J. Gastroenterol. Hepatol. - 2010; 22: 983-8.
- Lukicheva E., Tonkikh J., Kasparov E. et al. Lipid composition of bile, motor functions of the gallbladder and prevalence of biliary diseases in native inhabitants and new comers of Evenkia // Дальневосточный медицинский журнал. - 2011; 4: 23-6.
- Буторин Н.Н., Бичурина Т.Б., Цуканов В.В. и др. Распространенность и клинические аспекты пищевода Барретта у населения Восточной Сибири // Тер. арх. - 2013; 85 (1): 62-5.
- Цуканов В.В., Третьякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 22 (4): 27-31.
- Mendez-Sanchez N., Zamora-Valdes D., Chavez-Tapia N. et al. Role of diet in cholesterol gallstone formation // Clin. Chim. Acta. - 2007; 376: 1-8.
- Johansson K., Sundstrom J., Marcus C. et al. Risk ofsymptomatic gallstones and cholecystectomy after a very-low-calorie dietor low-calorie diet in a commercial weight loss program: 1-year matchedcohort study // Int. J. Obes. -2014; 38: 279-84.
- Festi D., Villanova N., Colecchia A. Risk factors for gallstone formation during weight loss // Clin. Gastroenterol. Hepatol. - 2015; 13: 613. ВРАЧ io'2oi6
- Stokes C., Gluud L., Casper M. et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials // Clin. Gastroenterol. Hepatol. - 2014; 12: 1090-100.
- Sugerman H., Brewer W., Shiffman M. et al. A multicenter, placebocontrolled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss // Am. J. Surg. - 1995; 169: 91-6.
- Attanasio R., Mainolfi A., Grimaldi F. et al. Somatostatin analogs and gallstones: a retrospective survey on a largeseries of acromegalic patients // J. Endocrinol. Invest. - 2008; 31: 704-10.
- Venneman N., van Erpecum K. Gallstone disease: primary and secondaryprevention // Best Pract. Res. Clin. Gastroenterol. - 2006; 20: 1063-73.
- Marjoribanks J., Farquhar C., Roberts H. et al. Long term hormone therapy for perimenopausal and postmenopausal women // Cochrane Database Syst. Rev. - 2012; 7: CD004143.
补充文件
